Type your tag names separated by a space and hit enter

Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis

Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis ID - 453888 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453888/all/Propranolol_and_sclerotherapy_in_the_prevention_of_gastrointestinal_rebleeding_in_patients_with_cirrhosis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -